CYSLTR2
Basic information
Region (hg38): 13:48653711-48711226
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYSLTR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 18 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 7 | 7 |
Variants in CYSLTR2
This is a list of pathogenic ClinVar variants found in the CYSLTR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-48706844-A-T | not specified | Likely benign (Dec 20, 2022) | ||
13-48706857-G-A | not specified | Likely benign (May 23, 2023) | ||
13-48706873-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
13-48706918-A-C | not specified | Uncertain significance (Jun 30, 2024) | ||
13-48706932-G-C | Benign (Jul 20, 2018) | |||
13-48706965-T-G | Likely benign (Mar 01, 2023) | |||
13-48707013-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
13-48707016-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
13-48707016-T-G | not specified | Uncertain significance (Mar 20, 2023) | ||
13-48707067-G-A | not specified | Uncertain significance (Aug 16, 2021) | ||
13-48707087-G-A | Benign (Apr 10, 2018) | |||
13-48707122-C-T | not specified | Uncertain significance (Aug 20, 2024) | ||
13-48707125-A-G | Likely benign (Mar 01, 2023) | |||
13-48707139-G-T | not specified | Uncertain significance (Apr 23, 2024) | ||
13-48707149-G-C | not specified | Uncertain significance (Dec 12, 2023) | ||
13-48707166-T-C | not specified | Uncertain significance (Jun 14, 2024) | ||
13-48707170-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
13-48707208-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
13-48707212-T-G | not specified | Uncertain significance (Jan 23, 2024) | ||
13-48707280-G-A | not specified | Uncertain significance (May 23, 2023) | ||
13-48707314-T-C | not specified | Likely benign (Nov 13, 2024) | ||
13-48707334-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
13-48707361-G-A | not specified | Uncertain significance (May 27, 2022) | ||
13-48707415-A-G | not specified | Uncertain significance (Aug 20, 2024) | ||
13-48707418-A-G | not specified | Uncertain significance (Oct 04, 2015) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYSLTR2 | protein_coding | protein_coding | ENST00000282018 | 1 | 2548 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000998 | 0.367 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.117 | 175 | 179 | 0.975 | 0.00000927 | 2255 |
Missense in Polyphen | 59 | 62.229 | 0.94812 | 822 | ||
Synonymous | 0.561 | 67 | 73.1 | 0.916 | 0.00000387 | 706 |
Loss of Function | 0.0209 | 6 | 6.06 | 0.991 | 2.61e-7 | 101 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for cysteinyl leukotrienes. The response is mediated via a G-protein that activates a phosphatidylinositol- calcium second messenger system. Stimulation by BAY u9773, a partial agonist, induces specific contractions of pulmonary veins and might also have an indirect role in the relaxation of the pulmonary vascular endothelium. The rank order of affinities for the leukotrienes is LTC4 = LTD4 >> LTE4.;
- Pathway
- Calcium signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Lung fibrosis;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;eicosanoid metabolism;Eicosanoid ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Leukotriene receptors;G alpha (q) signalling events;GPCR downstream signalling;Endothelins
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.805
- rvis_EVS
- 1.31
- rvis_percentile_EVS
- 94
Haploinsufficiency Scores
- pHI
- 0.135
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.192
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cysltr2
- Phenotype
- respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- immune response;G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;leukotriene signaling pathway
- Cellular component
- cellular_component;plasma membrane;integral component of plasma membrane
- Molecular function
- galanin receptor activity;leukotriene receptor activity;protein binding;G protein-coupled peptide receptor activity